mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.09 |
mRNA |
BCL-LZH-4 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.09 |
mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.09 |
mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
-0.075 |
0.09 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
GSK1059615 |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.1 |
mRNA |
QL-XI-92 |
GDSC1000 |
pan-cancer |
AAC |
0.05 |
0.1 |
mRNA |
pitstop2 |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.1 |
mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.1 |
mRNA |
YK 4-279 |
GDSC1000 |
pan-cancer |
AAC |
-0.059 |
0.1 |